AB was founded in 1993 by Alfred E. Mann with the mission to develop implantable patient care solutions that improve quality of life.
AB evolved from two highly successful companies that developed and marketed innovative medical devices; one created new generation pacemakers, and the other developed microinfusion systems (miniature drug delivery pumps used in the treatment of diabetes). The technology behind AB’s first cochlear implant system came from the pioneering research at the University of California, San Francisco.
Since its inception, AB has consistently made industry-leading advancements in technology innovations that have helped make a difference in the lives of thousands of families worldwide.
Today, AB offers the most sophisticated cochlear implant system on the market with five times more sound resolution than its competitors, designed to allow recipients to go beyond deciphering speech to hearing music.
Now working with Phonak under the Sonova Group, AB has access to industry-leading engineering and technologies for products currently under development. These revolutionary products are designed to deliver unparalleled hearing performance, comfort, and reliability for recipients.
